- Home
- ATRA vs MGN Comparison
ATRA vs MGN Comparison
Compare ATRA & MGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRA
- MGN
- Stock Information
- Founded
- ATRA 2012
- MGN 2020
- Country
- ATRA United States
- MGN Malaysia
- Employees
- ATRA N/A
- MGN N/A
- Industry
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- MGN
- Sector
- ATRA Health Care
- MGN
- Exchange
- ATRA Nasdaq
- MGN Nasdaq
- Market Cap
- ATRA 97.0M
- MGN 84.9M
- IPO Year
- ATRA 2014
- MGN 2025
- Fundamental
- Price
- ATRA $14.41
- MGN $3.36
- Analyst Decision
- ATRA Strong Buy
- MGN
- Analyst Count
- ATRA 3
- MGN 0
- Target Price
- ATRA $21.00
- MGN N/A
- AVG Volume (30 Days)
- ATRA 52.1K
- MGN 2.0M
- Earning Date
- ATRA 11-11-2025
- MGN 01-01-0001
- Dividend Yield
- ATRA N/A
- MGN N/A
- EPS Growth
- ATRA N/A
- MGN N/A
- EPS
- ATRA 0.56
- MGN 0.07
- Revenue
- ATRA $188,667,000.00
- MGN $13,484,571.00
- Revenue This Year
- ATRA N/A
- MGN N/A
- Revenue Next Year
- ATRA N/A
- MGN N/A
- P/E Ratio
- ATRA $25.58
- MGN $47.10
- Revenue Growth
- ATRA 202.41
- MGN N/A
- 52 Week Low
- ATRA $5.01
- MGN $2.84
- 52 Week High
- ATRA $18.71
- MGN $8.63
- Technical
- Relative Strength Index (RSI)
- ATRA 68.37
- MGN N/A
- Support Level
- ATRA $13.12
- MGN N/A
- Resistance Level
- ATRA $14.78
- MGN N/A
- Average True Range (ATR)
- ATRA 0.84
- MGN 0.00
- MACD
- ATRA 0.16
- MGN 0.00
- Stochastic Oscillator
- ATRA 86.14
- MGN 0.00
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).